ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Sanguinaria canadensis 8X

Also known as: Bloodroot, Sanguinaria, Sanguinaria canadensis

Overview

*Sanguinaria canadensis*, commonly known as Bloodroot, is a plant native to North America with a history of traditional medicinal use. It contains alkaloids, including sanguinarine, which are thought to contribute to its biological activities. Historically, it has been used for various purposes, including dental plaque reduction, skin condition treatment, and as an expectorant. However, its use is controversial due to potential toxicity. The plant's key characteristics stem from its benzophenanthridine alkaloids, which exhibit antimicrobial and anti-inflammatory properties. Research on *Sanguinaria canadensis* is limited, with most studies focusing on its phytochemical composition and traditional uses rather than rigorous clinical trials assessing its safety and efficacy. The available evidence is primarily observational and traditional, highlighting the need for more comprehensive research to validate its benefits and risks.

Benefits

There is limited evidence supporting specific health benefits from *Sanguinaria canadensis* in a clinical context. Traditional uses suggest potential antimicrobial and anti-inflammatory effects, but these are not well-documented in modern clinical trials. Potential benefits may include antimicrobial activity, but this is not well-documented in human studies. No specific population benefits are well-documented. Due to the lack of rigorous clinical trials, effect sizes and clinical significance are not well-established. More research is needed to determine the true efficacy and safety profile of *Sanguinaria canadensis*.

How it works

The alkaloids in *Sanguinaria canadensis*, particularly sanguinarine, may interact with biological pathways related to inflammation and microbial growth. Potential interactions include antimicrobial effects on oral flora and possible anti-inflammatory effects on skin and mucous membranes. The benzophenanthridine alkaloids may target microbial cell membranes and potentially influence inflammatory pathways. However, the exact mechanisms of action, absorption, and bioavailability are not well-studied, particularly in the context of oral supplementation. Further research is needed to fully elucidate how *Sanguinaria canadensis* interacts with the body.

Side effects

*Sanguinaria canadensis* can be toxic due to its alkaloid content, particularly sanguinarine, which has been associated with adverse effects like nausea, vomiting, and potential liver damage. Common side effects include nausea and vomiting. Uncommon side effects include diarrhea and abdominal pain. Rare side effects include potential liver damage, though this is rare and not well-documented. Drug interactions are not well-studied, but caution is advised due to potential toxicity. *Sanguinaria canadensis* is contraindicated in pregnancy, breastfeeding, and individuals with liver conditions. Children and elderly individuals should exercise caution due to potential toxicity. Due to the potential for serious adverse effects, it is crucial to consult with a healthcare professional before using *Sanguinaria canadensis*.

Dosage

A minimum effective dose for *Sanguinaria canadensis* has not been established due to limited clinical data. Traditional uses often involve small amounts, but modern clinical guidelines are lacking. A maximum safe dose is also not well-defined; caution is advised due to potential toxicity. Timing considerations are not established. It is typically used in topical or oral forms, but safety and efficacy vary widely. Absorption factors are not well-studied. Required cofactors are not established. Due to the potential for toxicity, it is crucial to adhere to conservative dosing guidelines and consult with a healthcare professional before using *Sanguinaria canadensis*.

FAQs

Is *Sanguinaria canadensis* safe to use?

Safety is a primary concern due to potential toxicity. Avoid use in vulnerable populations and consult a healthcare provider before using. Limited evidence supports specific health benefits.

What are the expected results from using *Sanguinaria canadensis*?

Limited evidence supports specific health benefits. There is a common misconception about its safety and efficacy without robust clinical evidence. Consult with a healthcare provider before use.

Are there any specific precautions I should take?

Avoid use in vulnerable populations, such as pregnant or breastfeeding women, and individuals with liver conditions. Consult a healthcare provider before using due to potential toxicity.

Research Sources

  • https://researchportal.scu.edu.au/esploro/outputs/journalArticle/Sanguinaria-canadensis-traditional-medicine-phytochemical-composition/991012821265702368 – This journal article discusses the traditional uses and phytochemical composition of *Sanguinaria canadensis*. It highlights the presence of benzophenanthridine alkaloids and their potential medicinal properties, emphasizing the need for further research to validate these traditional uses with modern clinical trials.
  • https://www.shisso-info.com/wp-content/uploads/2023/09/Therapeutic-recommendations-of-the-International-Homeopathic-Society-of-Supportive-Care-in-Oncology-IHSSC0.pdf – This document provides therapeutic recommendations from the International Homeopathic Society of Supportive Care in Oncology. It may include information on the use of *Sanguinaria canadensis* in homeopathic treatments, though the efficacy and safety of such uses should be critically evaluated.
  • https://pubmed.ncbi.nlm.nih.gov/29131443/ – This PubMed entry likely contains research on *Sanguinaria canadensis*. The summary would detail the study's objectives, methodology, and key findings, providing insights into the plant's potential effects and mechanisms of action.
  • https://patents.google.com/patent/WO2013106068A2/en – This patent application describes potential applications of *Sanguinaria canadensis*. The summary would outline the specific uses and formulations claimed in the patent, providing insights into innovative applications of the plant.
  • https://cursosextensao.usp.br/pluginfile.php/564958/mod_folder/content/0/Medical%20Herbalism%20-%20The%20Science%20and%20Practice%20of%20Herbal%20Medicine%20(2003).pdf – This PDF document likely covers the science and practice of herbal medicine, potentially including information on *Sanguinaria canadensis*. The summary would highlight the relevant sections discussing the plant's traditional uses, phytochemical composition, and potential therapeutic applications.